U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07057726) titled 'A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects' on Feb. 06.
Brief Summary: To evaluate the safety, tolerability, and pharmacokinetics of SSS39 injection in healthy Chinese subjects
Study Start Date: Oct. 09, 2024
Study Type: INTERVENTIONAL
Condition:
Safety and Tolerability in Healthy Volunteers
Intervention:
DRUG: SSS39
Single oral administration of SSS39
DRUG: SSS39
Single oral administration of SSS39
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Published by HT Digital Content Services with permission f...